First-Line Atezolizumab in Addition to Bevacizumab Plus Chemotherapy for Metastatic, Nonsquamous Non–Small Cell Lung Cancer: A United States–Based Cost-Effectiveness Analysis
发布时间：2020-02-26
点击次数：
发表刊物：Cancer
合写作者：Peng Liubao, Zhang Yucong, Zeng Xiaohui, Tan Chongqing, Luo Xia, Wan Xiaomin
卷号：125
期号：20
页面范围：3526-3534
是否译文：否